Mechanistic contribution of carnitine deficiency to geriatric frailty

Research output: Contribution to journalArticle

Abstract

Frailty is a geriatric syndrome characterized by muscle weakness, sarcopenia, and fatigue, and is associated with several adverse health outcomes, including disability. Design of therapeutic interventions for geriatric frailty has been challenging and may be because of inadequate understanding of its biological underpinnings. Carnitine is important for energy production in skeletal muscles and there seems to be a negative correlation between advancing age and muscle carnitine levels. Carnitine deficiency may therefore contribute to geriatric frailty. Age-associated carnitine deficiency from a variety of etiologies, including organic cation transporter (OCTN2) mutation and carnitine palmitoyltransferase II (CPT) deficiency, may potentially explain the relationship between carnitine-associated mitochondrial dysfunction and geriatric frailty. Development of therapeutic agents capable of prevention or reversal of carnitine deficiency in older adults may minimize the occurrence of frailty in geriatric populations.

Original languageEnglish (US)
Pages (from-to)265-268
Number of pages4
JournalAgeing Research Reviews
Volume9
Issue number3
DOIs
StatePublished - Jul 2010

Fingerprint

Geriatrics
Carnitine
Muscle
Sarcopenia
Carnitine O-Palmitoyltransferase
Muscle Fatigue
Muscle Weakness
Skeletal Muscle
Health
Fatigue of materials
Muscles
Mutation
Therapeutics
Population

Keywords

  • Aging
  • Carnitine
  • Frailty
  • Mitochondrion

ASJC Scopus subject areas

  • Aging
  • Biochemistry
  • Biotechnology
  • Molecular Biology
  • Neurology

Cite this

Mechanistic contribution of carnitine deficiency to geriatric frailty. / Crentsil, Victor.

In: Ageing Research Reviews, Vol. 9, No. 3, 07.2010, p. 265-268.

Research output: Contribution to journalArticle

@article{6a2c7406642c48809b75a06f21b859ed,
title = "Mechanistic contribution of carnitine deficiency to geriatric frailty",
abstract = "Frailty is a geriatric syndrome characterized by muscle weakness, sarcopenia, and fatigue, and is associated with several adverse health outcomes, including disability. Design of therapeutic interventions for geriatric frailty has been challenging and may be because of inadequate understanding of its biological underpinnings. Carnitine is important for energy production in skeletal muscles and there seems to be a negative correlation between advancing age and muscle carnitine levels. Carnitine deficiency may therefore contribute to geriatric frailty. Age-associated carnitine deficiency from a variety of etiologies, including organic cation transporter (OCTN2) mutation and carnitine palmitoyltransferase II (CPT) deficiency, may potentially explain the relationship between carnitine-associated mitochondrial dysfunction and geriatric frailty. Development of therapeutic agents capable of prevention or reversal of carnitine deficiency in older adults may minimize the occurrence of frailty in geriatric populations.",
keywords = "Aging, Carnitine, Frailty, Mitochondrion",
author = "Victor Crentsil",
year = "2010",
month = "7",
doi = "10.1016/j.arr.2010.02.005",
language = "English (US)",
volume = "9",
pages = "265--268",
journal = "Ageing Research Reviews",
issn = "1568-1637",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Mechanistic contribution of carnitine deficiency to geriatric frailty

AU - Crentsil, Victor

PY - 2010/7

Y1 - 2010/7

N2 - Frailty is a geriatric syndrome characterized by muscle weakness, sarcopenia, and fatigue, and is associated with several adverse health outcomes, including disability. Design of therapeutic interventions for geriatric frailty has been challenging and may be because of inadequate understanding of its biological underpinnings. Carnitine is important for energy production in skeletal muscles and there seems to be a negative correlation between advancing age and muscle carnitine levels. Carnitine deficiency may therefore contribute to geriatric frailty. Age-associated carnitine deficiency from a variety of etiologies, including organic cation transporter (OCTN2) mutation and carnitine palmitoyltransferase II (CPT) deficiency, may potentially explain the relationship between carnitine-associated mitochondrial dysfunction and geriatric frailty. Development of therapeutic agents capable of prevention or reversal of carnitine deficiency in older adults may minimize the occurrence of frailty in geriatric populations.

AB - Frailty is a geriatric syndrome characterized by muscle weakness, sarcopenia, and fatigue, and is associated with several adverse health outcomes, including disability. Design of therapeutic interventions for geriatric frailty has been challenging and may be because of inadequate understanding of its biological underpinnings. Carnitine is important for energy production in skeletal muscles and there seems to be a negative correlation between advancing age and muscle carnitine levels. Carnitine deficiency may therefore contribute to geriatric frailty. Age-associated carnitine deficiency from a variety of etiologies, including organic cation transporter (OCTN2) mutation and carnitine palmitoyltransferase II (CPT) deficiency, may potentially explain the relationship between carnitine-associated mitochondrial dysfunction and geriatric frailty. Development of therapeutic agents capable of prevention or reversal of carnitine deficiency in older adults may minimize the occurrence of frailty in geriatric populations.

KW - Aging

KW - Carnitine

KW - Frailty

KW - Mitochondrion

UR - http://www.scopus.com/inward/record.url?scp=77952546637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952546637&partnerID=8YFLogxK

U2 - 10.1016/j.arr.2010.02.005

DO - 10.1016/j.arr.2010.02.005

M3 - Article

C2 - 20223299

AN - SCOPUS:77952546637

VL - 9

SP - 265

EP - 268

JO - Ageing Research Reviews

JF - Ageing Research Reviews

SN - 1568-1637

IS - 3

ER -